Pemphigoid gestationis: a unique pregnancy-associated, organ-specific autoimmune disease

References

• Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin. Exp. Dermatol.24, 255–259 (1999).
   PubMed Web of Science ®Google Scholar
• Holmes RC, Black MM. The specific dermatoses of pregnancy: a reappraisal with special emphasis on a proposed simplified clinical classification. Clin. Exp. Dermatol.7, 65–73 (1982).
   PubMedGoogle Scholar
• Kolodny RC. Herpes gestationis: a new assessment of incidence, diagnosis, and fetal prognosis. Am. J. Obstet. Gynecol.104(1), 39–45 (1969).
   PubMedGoogle Scholar
• Shornick JK, Bangert JL, Freeman RG, Gilliam JN. Herpes gestationis: clinical and histological features of twenty eight cases. J. Am. Acad. Dermatol.8, 214–224 (1983).
   PubMed Web of Science ®Google Scholar
• Luppi P. How immune systems are affected by pregnancy. Vaccine21(24),3352–3357 (2003).
   PubMed Web of Science ®Google Scholar
• Provost TT, Tomasi TB. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J. Clin. Invest. 51, 1779–1787 (1973).
   Google Scholar
• Jordon RE, Heine KG, Tappheiner G, Bushkell LL, Provost TT. The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of the ‘HG’ factor. J. Clin. Invest.57, 1426–1433 (1976).
   PubMedGoogle Scholar
• Katz SI, Hertz KC, Yaoita H. Herpes gestationis: immunopathology and characterization of the HG factor. J. Clin. Invest.57, 1434–1441 (1976).
   PubMed Web of Science ®Google Scholar
• Morrison LH, Labib RS, Zone JJ, Anhalt GJ. Herpes gestationis antibodies recognize a 180-kD human epidermal antigen. J. Clin. Invest.81, 2023–2026 (1988).
   PubMed Web of Science ®Google Scholar
• Powell AM, Sakuma-Oyama Y, Oyama N, Black MM. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex.Clin. Exp. Dermatol.30, 682–687 (2005).
   PubMed Web of Science ®Google Scholar
• Kelly SE, Bhogal BS, Wojnarowska F, Black MM. Expression of a pemphigoid gestationis-related antigen by human Placenta Br. J. Dermatol.118, 605–611 (1988).
   PubMedGoogle Scholar
• Hofmann SC, Thoma-Uszynski S, Hunziker T et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J. Invest. Dermatol.119, 1065–1073 (2002).
   PubMed Web of Science ®Google Scholar
• Lin MS, Fu CL, Giudice GJ et al. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J. Invest. Dermatol.115, 955–961 (2000).
   PubMed Web of Science ®Google Scholar
• Balding SD, Prost C, Diaz LA et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J. Invest. Dermatol.106, 141–146 (1996).
   PubMedGoogle Scholar
• Komminga A, Scheckenbach C, Georgi M et al. Patients with bullous pemphigoid and linear IgA disease show dual IgA and IgG autoimmune response to BP180. J. Autoimmun.15, 293–300 (2000).
   PubMedGoogle Scholar
• Lin MS, Fu CL, Olague-Marchan M et al. Autoimmune responses in patients with linear IgA bullous dermatoses: both autoantibodies and T-lymphocytes recognise the NC16a domain of the BP180 molecule. Clin. Immunol.102, 310–319 (2002).
   PubMedGoogle Scholar
• Lin MS, Gharia M, Fu CL et al. Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. Clin. Immunol.92, 285–292 (1999).
   PubMedGoogle Scholar
• Shimanovich I, Skrobek C, Rose C et al. Pemphigoid gestationis with predominant involvement of the oral mucous membrane and IgA autoantibodies targeting the C-terminus of BP180. J. Am. Acad. Dermatol.47, 780–784 (2002).
   PubMedGoogle Scholar
• Liu Z, Diaz LA, Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemodesomosomal antigen, BP180. J. Clin. Invest.92, 2480–2488 (1993).
   PubMed Web of Science ®Google Scholar
• Liu Z, Diaz LA. Swartz SJ et al. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. J. Immunol.155, 5449–5454 (1995).
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Inoue N, Masuda R et al. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid, J. Invest. Dermatol.118, 485–492 (2002).
   PubMed Web of Science ®Google Scholar
• Schimdt E, Reimer S, Kruse N et al. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured keratinocytes. J. Invest. Dermatol.115, 842–848 (2000).
   PubMedGoogle Scholar
• Sitaru C, Schmidt E, Petermann S, Munteanu LS, Brocker EB, Zillikens D. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J. Invest. Dermatol.118, 664–671 (2002).
   PubMed Web of Science ®Google Scholar
• Liu Z. Bullous pemphigoid: using animal models to study the immunopathology. J. Invest. Dermatol. Symp. Proc.9, 41–46 (2004).
   PubMedGoogle Scholar
• Liu Z, Giudice GJ, Swartz SJ et al. The role of complement in experiental bullous pemphigoid. J. Clin. Invest.95, 1539–1544 (1995).
   PubMed Web of Science ®Google Scholar
• Liu Z, Giudice GJ, Zhou X et al. A major role for neutrophils in experimental bullous pemphigoid. J. Clin. Invest.100, 1256–1263 (1997).
   PubMed Web of Science ®Google Scholar
• Liu Z, Shipley JM, Vu TH et al. Gelatinase B deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med.188, 475–482 (1998).
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou X, Shapiro SD et al. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell102, 647–655 (2000).
   PubMed Web of Science ®Google Scholar
• Liu Z, Li N. Diaz LA, Shipley JM, Senior RM, Werb Z. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest.115, 879–887 (2005).
   PubMed Web of Science ®Google Scholar
• Kelly SE, Cerio R, Bhogal BS, Black MM. The distribution of IgG subclass in pemphigoid gestationis: PG factor is an IgG1 antibody. J. Invest. Dermatol.92, 695–698 (1989).
   PubMedGoogle Scholar
• Chimanovitch I, Schmidt E, Messer G et al. IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within the NC16A domain of BP180 in pemphigoid gestationis. J. Invest. Dermatol.113, 140–142 (1999).
   PubMed Web of Science ®Google Scholar
• Carruthers JA, Ewins AR. Herpes gestationis: studies on the binding characteristics, activity, and pathogenic significance of the complement fixing factor. Clin. Exp. Dermatol.31, 38–44 (1978).
   Google Scholar
• Shornick JD. Dermatoses of pregnancy. Semin Cutan. Med. Surg.17, 172–181 (1998).
   PubMedGoogle Scholar
• Scheman AJ, Hordinsky MD, Groth DW, Vercellotti GM, Leifferman KM. Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis. Arch. Dermatol.125, 1079–1083 (1989).
   PubMedGoogle Scholar
• Fabbri P, Caproni M, Berti S et al. The role of T lymphocytes and cytokines in the pathogenesis of pemphigoid gestationis. Br. J. Dermatol.148, 1141–1148 (2003).
   PubMedGoogle Scholar
• Gunther C, Wozel G, Dressler J, Meurer M, Pfeiffer C. Tissue eosinophilia in pemphigoid gestationis: an association with eotaxin and upregulated activation markers on transmigrated eosinophils. Am. J. Reprod. Immunol.51, 32–39 (2004).
   PubMedGoogle Scholar
• Borrego L, Peterson EA, Diez LI et al. Polymorphic eruption of pegnancy and herpes gestationis: comparison of granulated cell proteins in tissue and serum. Clin. Exp. Dermatol.24, 213–225 (1999).
   PubMedGoogle Scholar
• Shornick JK, Stastny P, Gilliam JN. High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestationis. J. Clin. Invest.68, 554–555 (1981).
   Google Scholar
• Holmes RC, Black MM, Dann J, James DC, Bhogal B. A comparative study of toxic erythema of pregnancy and herpes gestationis and toxic erythema of pregnancy. Br. J. Dermatol.106, 499–510 (1982).
   PubMedGoogle Scholar
• Shornick JK, Meek TJ, Nesbitt LT Jr, Gilliam JN. Herpes gestationis in blacks. Arch. Dermatol.120, 511–513 (1983).
   Google Scholar
• Garcia-González E, Castro-Llamas J, Karchmer S et al. Class II major histocompatability complex typing across the ethnic barrier in pemphigoid gestationis: a study in Mexicans. Int. J. Dermatol.38, 46–51 (1999).
   PubMedGoogle Scholar
• Shornick JK, Stastny P, Gilliam JN. Paternal histocompatibility (HLA) antigens and maternal anti-HLA antibodies in herpes gestationis. J. Invest. Dermatol.81, 407–409 (1983).
   PubMedGoogle Scholar
• Sherman LA, Chattopadhyay S. The molecular basis of allorecognition. Ann. Rev. Immunol.11, 385–402 (1993).
   PubMed Web of Science ®Google Scholar
• Lin MS, Gharia MA, Swartz SJ, Diaz LA, Giudice GJ. Identification and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis. J. Immunol.162, 4991–4997 (1999).
   PubMed Web of Science ®Google Scholar
• Büdinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J. Clin. Invest.102, 2082–2089 (1998).
   PubMed Web of Science ®Google Scholar
• Rico MJ, Benning C, Weingart ES. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris. Br. J. Dermatol.140, 1079–1086 (1999).
   PubMed Web of Science ®Google Scholar
• Fabbri P, Caproni M, Berti S et al. The role of T lymphocytes and cytokines in the pathogenesis of pemphigoid gestationis. Br. J. Dermatol.148, 1141–1148 (2003).
   PubMedGoogle Scholar
• Hacker-Foegen MK, Zillikens D, Giudice GJ, Lin MS. T cell receptor gene usage of BP180-specific T lmphocytes from patients with bullous pemphigoid and pemphigoid gestationis. Clin. Immunol.113, 179–186 (2004).
   PubMed Web of Science ®Google Scholar
• Shornick JK. Herpes gestationis. J. Am. Acad. Dermatol.17, 539–556 (1987).
   PubMed Web of Science ®Google Scholar
• Holmes RC, Black MM, Jurecka W et al. Clues to the aetiology and pathogenesis of herpes gestationis. Br. J. Dermatol.109, 131–139 (1983).
   PubMed Web of Science ®Google Scholar
• Oyama N, Bhogal BS, Carrington P, Gratian MJ, Black MM. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. Br. J. Dermatol.148, 939–944 (2003).
   PubMed Web of Science ®Google Scholar
• Kelly SE, Black MM, Fleming S. Antigen-presenting cells in the skin and placenta in pemphigoid gestationis. Br. J. Dermatol.122, 593–599 (1990).
   PubMedGoogle Scholar
• Borthwick GM, Holmes RC, Stirrat GM. Abnormal expression of class II MHC antigens in placentae from patients with pemphigoid gestationis. Placenta9, 81–94 (1988).
   PubMedGoogle Scholar
• Mincheva-Nilsson L. Pregnancy and γδ T cells: taking on the hard questions. Reprod. Biol. Endocrinol.1, 120–130 (2003).
   PubMedGoogle Scholar
• Huddleston H, Schust DJ. Immune interactions at the maternal–fetal interface: a focus on antigen presentation. Am. J. Reprod. Immunol.51, 283–289 (2004).
   PubMedGoogle Scholar
• Watanabe M, Iwatani Y, Kaneda T et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am. J. Reprod. Immunol.37, 368–377 (1997).
   PubMed Web of Science ®Google Scholar
• Lederman MM. Cell-mediated immunity and pregnancy. Chest86, 6S–9S (1984).
   PubMedGoogle Scholar
• Brabin BJ. Epidemiology of infection in pregnancy. Rev. Infect. Dis.7, 579–603 (1985).
   PubMedGoogle Scholar
• Da Silva JAP, Spector TD. The role of pregnancy in the course and etiology of rheumatoid arthritis. Clin. Rheumatol.11, 189 (1992).
   PubMedGoogle Scholar
• Langer-Gould A, Garren H, Slansky A, Ruiz PJ, Steinman L. Late pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: evidence for a suppressive pregnancy related serum factor. J. Immunol.169, 1084–1091 (2002).
   PubMedGoogle Scholar
• Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal replationship: is successful pregnancy a Th2 phenomenon? Immunol. Today14, 353–356 (1993).
   PubMedGoogle Scholar
• Shornick JK, Black MM. Secondary autoimmune diseases in herpes gestationis (pemphigoid gestationis). J. Am. Acad. Dermatol.26, 563–566 (1992).
   PubMedGoogle Scholar
• Al-Fares S, Vaughan Jones S, Black MM. The specific dermatoses of pregnancy: a reappraisal. J. Eur. Acad. Dermatol. Venerol.15, 197–206 (2001).
   PubMedGoogle Scholar
• Black MM. New observations on pemphigoid ‘herpes’ gestationis. Dermatology189(Suppl 1), 50–51 (1994).
   PubMedGoogle Scholar
• Jenkins RE, Vaughan Jones SA, Black MM. Conversion of pemphigoid gestationus to bullous pemphigoid – two refractory cases highlighting this association. Br. J. Dermatol.135, 595–598 (1995).
   Google Scholar
• Amato L, Mei S, Gallerani I, Moretti S, Fabbri P. A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? J. Am. Acad. Dermatol.49, 302–307 (2003).
   PubMedGoogle Scholar
• Boulinguez S, Bedane C, Prost C, Bernard P, Labbe L, Bonnetblanc JM. Chronic pemphigoid gestationis: comparative clinical and immunopathological study of 10 patients. Dermatology206, 113–119 (2003).
   PubMedGoogle Scholar
• Powell AM, Black MM. Epitope spreading: protection from pathogens but propagation of autoimmunity? Clin. Exp. Dermatol.26, 427–433 (2001).
   PubMedGoogle Scholar
• Shimanovich I, Bröcker EB, Zillikens D, Pemphigoid gestationis: new insights into the pathogenesis lead to novel diagnostic tools. Br. J. Obstet. Gynaecol.109, 970–976 (2002).
   Google Scholar
• Vaughan Jones SA, Hern S, Nelson-Piercy C et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br. J. Dermatol.141, 71–81 (1999).
   PubMedGoogle Scholar
• Hodge L, Black MM, Ramnarain N, Bhogal B. Indirect complement immunofluorescence in the immunopathological assessment of bullous pemphigoid, cicatricial pemphigoid and herpes gestationis. Clin. Exp. Dermatol.3, 61–67 (1978).
   PubMedGoogle Scholar
• Willsteed EM, Bhogal BS, Das A et al. An ultrastructural comparison of dermo-epidermal separation techniques. J. Cutan. Pathol.18, 8–12 (1991).
   PubMedGoogle Scholar
• Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br. J. Dermatol.118, 31–40 (1988).
   PubMed Web of Science ®Google Scholar
• Lazarova Z, Yancey KB. Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol.L salt-split skin. Specificity, sensntivity and practical consideration. J. Am. Acad. Dermatol.35, 398–403 (1996).
   PubMedGoogle Scholar
• Gammon WR, Briggaman RA, Inman AO III et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J. Invest. Dermatol.82, 139–144 (1984).
   PubMed Web of Science ®Google Scholar
• Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch. Dermatol.133, 1102–1107 (1997).
   PubMedGoogle Scholar
• Schmidt E, Kromminga A, Mimietz S et al. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180. J. Autoimm.18, 299–303 (2002).
   PubMedGoogle Scholar
• Towbin H, Staehelin T, Gordon J. Electrophorectic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA76, 4350–4354 (1979).
   PubMed Web of Science ®Google Scholar
• Murakami H, Amagai M, Hiashiyama M et al. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen. J. Dermatol. Sci.13, 112–117 (1996).
   PubMed Web of Science ®Google Scholar
• Giudice GJ, Emery DJ, Diaz LA. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J. Invest. Dermatol.99, 243–250 (1992).
   PubMed Web of Science ®Google Scholar
• Li K, Tamai K, Tan EML, Uitto J. Cloning of type XVII collagen. J. Biol. Chem.268, 8825–8834 (1993).
   PubMed Web of Science ®Google Scholar
• Giudice GJ, Wilske KC, Anhalt GJ et al. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J. Invest. Dermatol.102, 878–881 (1994).
   PubMed Web of Science ®Google Scholar
• Nakatani C, Muramatsu T, Shirai T. Immuoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16a and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme linked immunosorbent assay using BP180 recombinant proteins. Br. J. Dermatol.139, 365–370 (1998).
   PubMedGoogle Scholar
• Zillikens D, Mascaro JM, Rose PA et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J. Invest. Dermatol.109, 679–683 (1997).
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Amagai M, Kuroda-Kinoshita K et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J. Dermatol. Sci.30, 224–232 (2002).
   PubMed Web of Science ®Google Scholar
• Hata Y, Fujii Y, Tsunoda K, Amagai M. Production of the entire extracellular domain of BP180 (type XVII collagen) by baculovirus expression. J. Dermatol. Sci.23, 183–190 (2000).
   PubMedGoogle Scholar
• Haase C, Büdinger L, Borradori L et al. Detection of IgG autoantibodies in the sera of patients with bullous pemphigoid and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen-2. J. Invest. Dermatol.11, 282–286 (1998).
   Google Scholar
• Kidd IM, Emery VC. The use of baculoviruses as expression vectors. Appl. Biochem. Biotechnol.42, 137–159 (1993).
   PubMedGoogle Scholar
• Powell AM, Sakuma-Oyama Y, Oyama N et al. The usefulness of BP180 NC16a enzyme-linked immunosorbent assay (ELISA) in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy (PUPPP). Arch. Dermatol.141, 705–710 (2005).
   PubMedGoogle Scholar
• Castle SP, Mather-Mondrey M, Bennion S, David-Bajar K, Huff K. Chronic herpes gestationis and antiphospholipid antibody syndrome successfully treated with cyclophosphamide. J. Am. Acad. Dermatol.34, 333–336 (1996).
   PubMedGoogle Scholar
• Burkhart CG. Pyridoxine-responsive herpes gestationis. Arch. Dermatol.118, 535 (1982).
   PubMedGoogle Scholar
• Fine JD, Omura EF. Herpes gestationis: persistent disease activity 11-years post partum. Arch. Dermatol.121, 924–926 (1985).
   PubMedGoogle Scholar
• Garvey MP, Handfield Jones SE, Black MM. Pemphigoid gestationis: response to chemical oophorectomy with goserelin. Clin. Exp. Dermatol.17, 443–445 (1992).
   PubMed Web of Science ®Google Scholar
• Van de Wiel A, Hart HC, Flinterman J, Kerckhaert JA, Du Boeuff JA, Imhof JW. Plasma exchange in herpes gestationis. Br. Med. J.281, 1041–1042 (1980).
   PubMedGoogle Scholar
• Hern S, Harman K, Bhogal BS, Black MM. A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporine. Clin. Exp. Dermatol.23, 185–188 (1998).
   PubMed Web of Science ®Google Scholar
• Pinsky L, DiGeorge AM. Cleft palate in the mouse: a teratogenic index of glucocorticoid potency. Science147, 402–403 (1965).
   PubMed Web of Science ®Google Scholar
• Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology51, 45–46 (1985).
   Google Scholar
• Park-Wyllie L, Mazzotta P, Patusszak A et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology62, 385–392 (2000).
   PubMedGoogle Scholar
• Reinisch JM, Simon NG. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science202, 436–438 (1978).
   PubMed Web of Science ®Google Scholar
• Kraus AM. Congenital cataract and maternal steroid injection. J. Paediatr. Ophthamol. Strabismus.12, 107–108 (1975).
   Google Scholar
• Kozlowska-Boszko B, Soluch L, Rybus J, Lao M, Durlik M, Gaciong Z. Does chronic glucosteroid therapy in pregnant renal allograft recipients affect cortisol levels in neonates. Transpl. Proc.28, 3490–34901 (1996).
   PubMedGoogle Scholar
• Østensen M. Disease specific problems relating to drug therapy in pregnancy. Lupus13, 746–750 (2004).
   PubMed Web of Science ®Google Scholar
• Sasseville D, Wilkinson RD, Schnader JY. Dermatoses of pregnancy. Int. J. Dermatol.20, 223–241 (1981).
   PubMed Web of Science ®Google Scholar
• Katz SI. Herpes gestationis. In: Dermatology in General Medicine, 4th Edition. Fitzpatrick TB, Eisen AZ, Wolff K et al (Eds). McGraw-Hill, NY, USA, 626–629 (1993).
   Google Scholar
• Kidd P. Th1/Th2 balance: the hypothesis, its limitations and implications for health and disease. Alt. Med. Rev.8, 223–246 (2003).
   PubMedGoogle Scholar
• Holmes RC, Black MM. The foetal prognosis in pemphigoid gestationis. Br. J. Dermatol.110, 67–72 (1984).
   PubMed Web of Science ®Google Scholar
• Kelly SE, Fleming S, Bhogal BS, Wojnarowska F, Black MM. Immunopathology of the placenta in pemphigoid gestationis and linear IgA disease. Br. J. Dermatol.120, 735–743 (1989).
   PubMed Web of Science ®Google Scholar
• Mascaro JM Jr, Lecha M, Mascaro JM. Fetal morbidity in herpes gestationis. Arch. Dermatol.131, 1209–1210 (1995).
   PubMedGoogle Scholar
• Lawley TJ, Stingl G, Katz SI. Fetal and maternal risk factors in herpes gestationis. Arch. Dermatol.114, 552–555 (1978).
   PubMedGoogle Scholar
• Van de Perre P. Transfer of antibody via mother’s milk. Vaccine. 21, 3374–3376 (2003).
   PubMed Web of Science ®Google Scholar
• Engineer L, Bhol K, Ahmed AR. Pemphigoid gestationis: a review. Am. J. Obstet. Gynecol.183, 483–491 (2000).
   PubMed Web of Science ®Google Scholar